explore -WSS

explore

author：Wikipedia 2025-10-01 15:31:04 - browse：58

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Bristol Myers buys into radiopharmaceuticals with RayzeBio

hotspot

leisure time

WSS

Virtual care provider acquires bankrupt Pear's prescription apps

Rare Northern Lights show in US this week: Where and how to see it

CRISPR gene editing developments we’re watching in 2024

The PBM ad wars are taking over Washington, D.C.

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

CRISPR gene editing developments we’re watching in 2024

Wikipedia

explore

explore

Supreme Court strikes down use of affirmative action

House panel to mark up pandemic

Jerome Adams on the need for new antivirals for Covid

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Guidelines to prevent youth baseball injuries need more muscle

In Spain, a hospital brews its own CAR

Duchenne breakthrough therapy leaves behind pioneering families

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Walensky prepares to leave CDC — and Congress — behind

UPS workers' union leader explains what's at stake as strike edges closer

entertainment

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Medicare drug price negotiation hasn't dried up venture capital

Prime Medicine, Myeloid Therapeutics clash over genome

How corporate America is slashing DEI workers amid backlash to diversity programs

Why Titanic fascinates society, still drawing tours to the wreckage

With fresh data, a dynamic duo powers Eli Lilly to new heights

knowledge

hotspot

leisure time

leisure time